Summit Clinical Research Solutions

Summit Clinical Research Solutions is an integrated clinical research organization (CRO) and integrated research organization (IRO) specializing in complex therapeutic areas, including metabolic dysfunction-associated steatohepatitis (MASH), obesity, and Alzheimer's disease. Formed in May 2026 through the unification of Summit Clinical Research and Pinnacle Clinical Research, the company provides a comprehensive, unified ecosystem spanning site operations, partner-site networks, patient recruitment, medical communications, and early-phase CRO services. Summit operates through five coordinated platforms: Pinnacle (an integrated site network), Elevation (global partner-site network and IRO services), Apogee (centralized patient recruitment), Ascend (medical communications), and Apex (early-phase CRO capabilities). Backed by private equity firm LongueVue Capital, Summit supports pharmaceutical and biotechnology sponsors in accelerating and optimizing clinical development across the clinical trial lifecycle.